BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
-0.42%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$137M
AUM Growth
+$137M
(-1%)
Cap. Flow
+$2.64M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
73.24%
Holding
64
New
1
Increased
15
Reduced
6
Closed
4
Top Buys
| 1 |
Ovintiv
OVV
|
$2.21M |
| 2 |
Phreesia
PHR
|
$1.82M |
| 3 |
Prothena Corp
PRTA
|
$1.64M |
| 4 |
Biodesix
BDSX
|
$903K |
| 5 |
Masimo
MASI
|
$784K |
Top Sells
| 1 |
Biogen
BIIB
|
$2.13M |
| 2 |
Bristol-Myers Squibb
BMY
|
$2.03M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$987K |
| 4 |
United Therapeutics
UTHR
|
$707K |
| 5 |
Vanda Pharmaceuticals
VNDA
|
$566K |
Sector Composition
| 1 | Healthcare | 93.73% |
| 2 | Energy | 3.94% |
| 3 | Consumer Staples | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $56M | 40.76% | 727,785 -26,321 | -3% | -$2.03M |
|
2
Elutia
ELUT
$96.7M
| $10M | 7.29% | 1,418,123 +200 | +0% | +$1.41K |
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $8.31M | 6.04% | 85,240 -4,000 | -4% | -$390K |
|
4
QuidelOrtho
QDEL
$1.95B
| $5.96M | 4.33% | 61,306 +1,622 | +3% | +$158K |
|
5
Foghorn Therapeutics
FHTX
$286M
| $3.87M | 2.82% | 284,843 -9,300 | -3% | -$126K |
|
|
6
Ovintiv
OVV
$10.8B
| $3.72M | 2.71% | 84,200 +50,000 | +146% | +$2.21M |
|
|
7
United Therapeutics
UTHR
$13.8B
| $3.54M | 2.57% | 15,000 -3,000 | -17% | -$707K |
|
8
Acadia Pharmaceuticals
ACAD
$4.38B
| $3.51M | 2.56% | 249,400 +50,000 | +25% | +$704K |
|
|
9
Biodesix
BDSX
$62.6M
| $2.93M | 2.13% | 1,811,412 +558,659 | +45% | +$903K |
|
|
10
Prothena Corp
PRTA
$441M
| $2.78M | 2.03% | 102,548 +60,570 | +144% | +$1.64M |
|
|
CLR
11
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $2.52M | 1.84% | 38,600 | – | – |
|
|
ALBO
12
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $2.24M | 1.63% | 113,000 | – | – |
|
|
AXDX
13
DELISTED
Accelerate Diagnostics
AXDX
| $2.24M | 1.63% | 2,252,388 | – | – |
|
|
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.19M | 1.59% | 15,000 +1,000 | +7% | +$146K |
|
|
15
Phreesia
PHR
$1.88B
| $2.07M | 1.5% | 82,700 +72,700 | +727% | +$1.82M |
|
|
16
Masimo
MASI
$7.59B
| $2M | 1.45% | 15,280 +6,000 | +65% | +$784K |
|
17
Alkermes
ALKS
$4.78B
| $1.49M | 1.08% | 50,000 | – | – |
|
18
Gossamer Bio
GOSS
$562M
| $1.33M | 0.97% | 159,088 +30,000 | +23% | +$251K |
|
19
Harrow
HROW
$1.44B
| $1.31M | 0.95% | 180,000 | – | – |
|
20
Karyopharm Therapeutics
KPTI
$61.7M
| $1.22M | 0.88% | 269,332 | – | – |
|
21
Corcept Therapeutics
CORT
$7.35B
| $1.19M | 0.86% | 50,000 | – | – |
|
22
Cytokinetics
CYTK
$4.23B
| $982K | 0.71% | 25,000 | – | – |
|
|
AVEO
23
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $918K | 0.67% | 140,000 | – | – |
|
|
PXD
24
DELISTED
Pioneer Natural Resource Co.
PXD
| $848K | 0.62% | 3,800 | – | – |
|
|
ETRN
25
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $846K | 0.62% | 133,050 | – | – |
|